54 related articles for article (PubMed ID: 15762219)
1. Two cases of cytokeratin positivity in atypical fibroxanthoma.
Bansal C; Sinkre P; Stewart D; Cockerell CJ
J Clin Pathol; 2007 Jun; 60(6):716-7. PubMed ID: 17483246
[No Abstract] [Full Text] [Related]
2. Atypical fibroxanthoma.
Sakamoto A
Clin Med Oncol; 2008; 2():117-27. PubMed ID: 21892274
[TBL] [Abstract][Full Text] [Related]
3. A Tale of Two Tumors: A Collision Tumor of Atypical Fibroxanthoma and Basal Cell Carcinoma.
Dhaliwal D; Sayyadioskoie S; Siatecka H; Hunt C; Diwan AH
Am J Dermatopathol; 2024 May; 46(5):309-311. PubMed ID: 38574065
[TBL] [Abstract][Full Text] [Related]
4. Keloidal atypical fibroxanthoma of the scalp.
McClelland K; Brady A; Reid P; Houghton J
BMJ Case Rep; 2023 Nov; 16(11):. PubMed ID: 37973539
[TBL] [Abstract][Full Text] [Related]
5. Genomic analysis of atypical fibroxanthoma.
Lai K; Harwood CA; Purdie KJ; Proby CM; Leigh IM; Ravi N; Mully TW; Brooks L; Sandoval PM; Rosenblum MD; Arron ST
PLoS One; 2017; 12(11):e0188272. PubMed ID: 29141020
[TBL] [Abstract][Full Text] [Related]
6. Metastatic atypical fibroxanthoma: a series of 11 cases including with minimal and no subcutaneous involvement.
Wang WL; Torres-Cabala C; Curry JL; Ivan D; McLemore M; Tetzlaff M; Zembowicz A; Prieto VG; Lazar AJ
Am J Dermatopathol; 2015 Jun; 37(6):455-61. PubMed ID: 25590287
[TBL] [Abstract][Full Text] [Related]
7. Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma: Updates on Classification and Management.
Soleymani T; Aasi SZ; Novoa R; Hollmig ST
Dermatol Clin; 2019 Jul; 37(3):253-259. PubMed ID: 31084719
[TBL] [Abstract][Full Text] [Related]
8. Pleomorphic Dermal Sarcoma With Metastasis to the Lung: A Case Report.
Shafi S; Bechtel M; Contreras CM; Plaza JA
Am J Dermatopathol; 2023 Oct; 45(10):708-711. PubMed ID: 37335842
[TBL] [Abstract][Full Text] [Related]
9. Atypical Fibroxanthoma: Outcomes from a Large Single Institution Series.
McClure E; Carr MJ; Patel A; Hussnain Naqvi SM; Kim Y; Harrington M; Cruse W; Gonzalez RJ; Sondak VK; Sarnaik AA; Messina JL; Zager JS
Cancer Control; 2023; 30():10732748231155699. PubMed ID: 36764930
[TBL] [Abstract][Full Text] [Related]
10. Hemato-Oncological Diseases as Risk Factor for Recurrence or Metastasis of Pleomorphic Dermal Sarcoma.
Helbig D
Front Oncol; 2022; 12():873771. PubMed ID: 35494063
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous soft tissue sarcomas: survival-related factors.
Gkantaifi A; Diamantis A; Mauri D; Nixon I; Kyriazoglou A; Baloyiannis I; Tsoukalas N; Charalampakis N; Schizas D; Cuccia F; Alongi F; de Mello RA; Iliadis G; Kamposioras K; Mazonakis M; Tolia M
Arch Dermatol Res; 2022 Sep; 314(7):625-631. PubMed ID: 34272971
[TBL] [Abstract][Full Text] [Related]
12. Electrochemotherapy as Promising Treatment Option in Rare Recurrent Cutaneous Neoplasm of the Scalp: Case Report of an Elderly Patient.
Crimini E; Roberto M; Degli Effetti V; Marchetti P; Botticelli A; Schipilliti FM; Arrivi G; Mazzuca F
Case Rep Oncol Med; 2019; 2019():2507642. PubMed ID: 31049235
[TBL] [Abstract][Full Text] [Related]
13. Conception and Management of a Poorly Understood Spectrum of Dermatologic Neoplasms: Atypical Fibroxanthoma, Pleomorphic Dermal Sarcoma, and Undifferentiated Pleomorphic Sarcoma.
Soleymani T; Tyler Hollmig S
Curr Treat Options Oncol; 2017 Aug; 18(8):50. PubMed ID: 28762020
[TBL] [Abstract][Full Text] [Related]
14. Incidence and Clinical Features of Rare Cutaneous Malignancies in Olmsted County, Minnesota, 2000 to 2010.
Tolkachjov SN; Schmitt AR; Muzic JG; Weaver AL; Baum CL
Dermatol Surg; 2017 Jan; 43(1):116-124. PubMed ID: 28027201
[TBL] [Abstract][Full Text] [Related]
15. Atypical fibroxanthoma of the scalp with recurrent and multiple regional cutaneous metastases.
Nergard J; Glener J; Reimer D; Greenwald JS
JAAD Case Rep; 2016 Nov; 2(6):491-493. PubMed ID: 27981227
[No Abstract] [Full Text] [Related]
16. Identification of potential therapeutic targets in human head & neck squamous cell carcinoma.
Han J; Kioi M; Chu WS; Kasperbauer JL; Strome SE; Puri RK
Head Neck Oncol; 2009 Jul; 1():27. PubMed ID: 19602232
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic utility of P63 and CD10 in distinguishing cutaneous spindle cell/sarcomatoid squamous cell carcinomas and atypical fibroxanthomas.
Hall JM; Saenger JS; Fadare O
Int J Clin Exp Pathol; 2008 Mar; 1(6):524-30. PubMed ID: 18787630
[TBL] [Abstract][Full Text] [Related]
18. [Recurrent and metastasizing atypical fibroxanthoma].
Koch M; Dimmler A; Alexiou C
HNO; 2008 Oct; 56(10):1046-51. PubMed ID: 18210006
[TBL] [Abstract][Full Text] [Related]
19. Metastasizing atypical fibroxanthoma (cutaneous malignant histiocytoma): report of five cases.
Cooper JZ; Newman SR; Scott GA; Brown MD
Dermatol Surg; 2005 Feb; 31(2):221-5; discussion 225. PubMed ID: 15762219
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
